North America Clinical Laboratory Services Market - Industry Trends and Forecast to 2028

Description

List of Tables

North America clinical laboratory services market is projected to register a CAGR of 7.3% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028

Market Segmentation:

North America Clinical Laboratory Services Market, By Service Type (Routine Testing Services, Esoteric Services, and Anatomic Pathology Services), Specialty (Clinical Chemistry Testing, Hematology Testing, Microbiology Testing, Immunology Testing, Drugs of Abuse Testing, Cytology Testing, and Genetic Testing), Provider (Hospital-Based Laboratories, Independent & Reference Laboratories, Nursing and Physician Office-Based Laboratories), Application (Drug Discovery Related Services, Drug Development Related Services, Bioanalytical & Lab Chemistry Services, Toxicology Testing Services, Cell & Gene Therapy Related Services, Preclinical & Clinical Trial Related Services And Other Clinical Laboratory Service) Industry Trends and Forecast to 2028.

Some of the major factors contributing to the growth of the North America clinical laboratory services market are:

Rise in demand for early and accurate disease diagnosis

Advancement in clinical diagnostic methods

Market Players:

Some of the major players operating in North America clinical laboratory services market are:

Genomic Health

Abbott

Charles River

H.U. Group Holdings, Inc.

Eurofins Scientific

Laboratory Corporation of America Holding

Mayo Foundation for Medical Education and Research

DaVita Inc.

Quest Diagnostics Incorporated

Siemens Healthcare GmbH

ARUP Laboratories

Lifelabs

BioReference Laboratories, Inc. (A subsidiary of OPKO Health, Inc.)

NeoGenomics Laboratories, Inc.

ACM Global Laboratories

1 INTRODUCTION 13

1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 OVERVIEW OF THE NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET 13
1.4 LIMITATIONS 15
1.5 MARKETS COVERED 15

2 MARKET SEGMENTATION 17

2.1 MARKETS COVERED 17
2.2 GEOGRAPHICAL SCOPE 18
2.3 YEARS CONSIDERED FOR THE STUDY 18
2.4 CURRENCY AND PRICING 18
2.5 DBMR TRIPOD DATA VALIDATION MODEL 19
2.6 MULTIVARIATE MODELLING 22
2.7 SERVICE TYPE LIFELINE CURVE 22
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 23
2.9 DBMR MARKET POSITION GRID 24
2.10 MARKET APPLICATION COVERAGE GRID 26
2.11 VENDOR SHARE ANALYSIS 27
2.12 SECONDARY SOURCES 28
2.13 ASSUMPTIONS 28

3 EXECUTIVE SUMMARY 29

4 PREMIUM INSIGHTS 32

4.1 OVERVIEW OF ADJACENT BUSINESS 33
4.2 IMPACT OF POINT OF CARE TESTING MARKET ON CLINICAL LABORATORY TESTING MARKET 33
4.3 IMPACT OF BIOMETRIC SCREENING MARKET ON CLINICAL LABORATORY TESTING MARKET 34
4.4 IMPACT OF MOLECULAR DIAGNOSTICS MARKET ON CLINICAL LABORATORY TESTING MARKET 34
4.5 CONCLUSION 34

5 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: REGULATIONS 35

5.1 REGULATION IN THE U.S. 35

6 GLOBAL CLINICAL LABORATORY SERVICES MARKET: REIMBURSEMENTS 37

6.1 REIMBURSEMENT IN THE U.S. FOR CLINICAL LABORATORY SERVICES 37

7 MARKET OVERVIEW 39

7.1 DRIVERS 41
- 7.1.1 RISE IN INFECTIOUS DISEASES 41
- 7.1.2 ADVANCEMENT IN CLINICAL DIAGNOSTIC METHODS 42
- 7.1.3 DEVELOPMENT IN DATABASE MANAGEMENT TOOLS AND WIDE ACCEPTANCE OF POINT-OF-CARE (POC) TESTING SOLUTIONS 42
- 7.1.4 RISE IN DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS 43
- 7.1.5 INCREASE IN APPLICATION OF HIGH-THROUGHPUT ASSAYS 43
7.2 RESTRAINTS 44
- 7.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 44
- 7.2.2 STRICT REGULATORY POLICIES 45
7.3 OPPORTUNITIES 46
- 7.3.1 INCREASE IN ADOPTION OF DIGITAL PATHOLOGY PLATFORMS 46
- 7.3.2 RISE IN PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 47
- 7.3.3 INCREASE IN AWARENESS ABOUT DIAGNOSIS AND TREATMENT OF THE DISEASE 47
- 7.3.4 STRATEGIC INITIATIVES BY MARKET PLAYERS 48
7.4 CHALLENGES 49
- 7.4.1 INACCURATE RESULTS OF TESTS 49
- 7.4.2 INADEQUATE REIMBURSEMENTS POLICIES 50

8 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE 51

8.1 OVERVIEW 52
8.2 ROUTINE TESTING SERVICES 53
- 8.2.1 ROUTINE CHEMISTRY TESTING 53
- 8.2.2 ROUTINE HEMATOLOGY TESTING 54
- 8.2.3 URINALYSIS TESTING 54
- 8.2.4 SUBSTANCE ABUSE TESTING 54
- 8.2.5 OTHERS 54
8.3 ESOTERIC SERVICES 54
8.4 ANATOMIC PATHOLOGY SERVICES 54
- 8.4.1 CYTOLOGY TESTING 55
- 8.4.2 DIAGNOSTIC SURGICAL PATHOLOGY TESTING 55
- 8.4.3 AUTOPSY PATHOLOGY 55
- 8.4.4 OTHERS 55

9 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY 56

9.1 OVERVIEW 57
9.2 CLINICAL CHEMISTRY TESTING 59
- 9.2.1 ROUTINE CHEMISTRY TESTING 59
- 9.2.2 THERAPEUTIC DRUG MONITORING (TDM) TESTING 59
- 9.2.3 SPECIALIZED CHEMISTRY TESTING 60
- 9.2.4 OTHER CLINICAL CHEMISTRY TESTING 60
9.3 HEMATOLOGY TESTING 60
- 9.3.1 ROUTINE HEMATOLOGY TESTING 60
- 9.3.2 SPECIALIZED HEMATOLOGY TESTING 60
- 9.3.3 COAGULATION TESTING 61
9.4 MICROBIOLOGY TESTING 61
- 9.4.1 INFECTIOUS DISEASE TESTING 61
- 9.4.2 TRANSPLANT DIAGNOSTIC TESTING 61
- 9.4.3 OTHER MICROBIOLOGY TESTING 61
9.5 IMMUNOLOGY TESTING 62
9.6 DRUGS OF ABUSE TESTING 62
9.7 CYTOLOGY TESTING 62
9.8 GENETIC TESTING 63

10 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER 64

10.1 OVERVIEW 65
10.2 HOSPITAL-BASED LABORATORIES 66
10.3 INDEPENDENT & REFERENCE LABORATORIES 66
10.4 NURSING AND PHYSICIAN OFFICE-BASED LABORATORIES 67

11 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION 68

11.1 OVERVIEW 69
11.2 BIOANALYTICAL & LAB CHEMISTRY SERVICES 70
11.3 DRUG DEVELOPMENT RELATED SERVICES 70
11.4 DRUG DISCOVERY RELATED SERVICES 71
11.5 TOXICOLOGY TESTING SERVICES 71
11.6 CELL & GENE THERAPY RELATED SERVICES 72
11.7 PRECLINICAL & CLINICAL TRIAL RELATED SERVICES 72
11.8 OTHER CLINICAL LABORATORY SERVICES 72

12 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY REGION 73

12.1 OVERVIEW 74
- 12.1.1 U.S. 81
- 12.1.2 CANADA 84
- 12.1.3 MEXICO 87

13 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: COMPANY LANDSCAPE 90

13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 90

14 SWOT ANALYSIS 91

15 COMPANY PROFILE 92

15.1 MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 92
- 15.1.1 COMPANY SNAPSHOT 92
- 15.1.2 SERVICE PORTFOLIO 92
- 16.1.1 RECENT DEVELOPMENTS 96
16.2 LABORATORY CORPORATION OF AMERICA 97
- 16.2.1 COMPANY SNAPSHOT 97
- 16.2.2 REVENUE ANALYSIS 98
- 16.2.3 SERVICE PORTFOLIO 98
- 16.2.4 RECENT DEVELOPMENTS 99
16.3 QUEST DIAGNOSTICS INCORPORATED 101
- 16.3.1 COMPANY SNAPSHOT 101
- 16.3.2 REVENUE ANALYSIS 102
- 16.3.3 SERVICE PORTFOLIO 102
- 16.3.4 RECENT DEVELOPMENTS 103
16.4 DAVITA INC. 105
- 16.4.1 COMPANY SNAPSHOT 105
- 16.4.2 REVENUE ANALYSIS 105
- 16.4.3 SERVICE PORTFOLIO 106
- 16.4.4 RECENT DEVELOPMENTS 106
16.5 SIEMENS HEALTHINEERS GMBH 107
- 16.5.1 COMPANY SNAPSHOT 107
- 16.5.2 REVENUE ANALYSIS 107
- 16.5.3 SERVICE PORTFOLIO 108
- 16.5.4 RECENT DEVELOPMENTS 108
16.6 SONIC HEALTHCARE 109
- 16.6.1 COMPANY SNAPSHOT 109
- 16.6.2 REVENUE ANALYSIS 110
- 16.6.3 SERVICE PORTFOLIO 110
- 16.6.4 RECENT DEVELOPMENTS 111
16.7 ABBOTT 112
- 16.7.1 COMPANY SNAPSHOT 112
- 16.7.2 REVENUE ANALYSIS 113
- 16.7.3 PRODUCT PORTFOLIO 113
- 16.7.4 RECENT DEVELOPMENTS 114
16.8 ACM GLOBAL LABORATORIES 116
- 16.8.1 COMPANY SNAPSHOT 116
- 16.8.2 SERVICE PORTFOLIO 116
- 16.8.3 RECENT DEVELOPMENTS 117
16.9 BIOREFERENCE LABORATORIES, INC. (A SUBSIDIARY OF OPKO HEALTH, INC.) 118
- 16.9.1 COMPANY SNAPSHOT 118
- 16.9.2 REVENUE ANALYSIS 118
- 16.9.3 SERVICE PORTFOLIO 119
- 16.9.4 RECENT DEVELOPMENTS 119
16.10 CHARLES RIVER 121
- 16.10.1 COMPANY SNAPSHOT 121
- 16.10.2 REVENUE ANALYSIS 121
- 16.10.3 SERVICE PORTFOLIO 122
- 16.10.4 RECENT DEVELOPMENTS 123
16.11 EUROFINS SCIENTIFIC 125
- 16.11.1 COMPANY SNAPSHOT 125
- 16.11.2 REVENUE ANALYSIS 125
- 16.11.3 SERVICE PORTFOLIO 126
- 16.11.4 RECENT DEVELOPMENTS 126
16.12 GENOMIC HEALTH 127
- 16.12.1 COMPANY SNAPSHOT 127
- 16.12.2 REVENUE ANALYSIS 127
- 16.12.3 PRODUCT PORTFOLIO 128
- 16.12.4 RECENT DEVELOPMENTS 128
16.13 H.U. GROUP HOLDINGS, INC. 129
- 16.13.1 COMPANY SNAPSHOT 129
- 16.13.2 REVENUE ANALYSIS 130
- 16.13.3 SERVICE PORTFOLIO 130
- 16.13.4 RECENT DEVELOPMENTS 131
16.14 LIFELABS 132
- 16.14.1 COMPANY SNAPSHOT 132
- 16.14.2 SERVICE PORTFOLIO 132
- 16.14.3 RECENT DEVELOPMENTS 132
16.15 NEOGENOMICS LABORATORIES, INC. 134
- 16.15.1 COMPANY SNAPSHOT 134
- 16.15.2 REVENUE ANALYSIS 134
- 16.15.3 SERVICE PORTFOLIO 135
- 16.15.4 RECENT DEVELOPMENTS 135

17 QUESTIONNAIRE 136

18 RELATED REPORTS 139

LIST OF TABLES

TABLE 1 NUMBER OF CORONAVIRUS (COVID-19) TESTS PERFORMED IN THE MOST IMPACTED COUNTRIES WORLDWIDE AS OF JULY 27, 2021 47
TABLE 2 TYPES AND RATES OF ERROR IN THE 3 STAGES OF THE LABORATORY TESTING PROCESS 49
TABLE 3 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION) 53
TABLE 4 NORTH AMERICA ROUTINE TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE 2019-2028 (USD MILLION) 53
TABLE 5 NORTH AMERICA ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE 2019-2028 (USD MILLION) 55
TABLE 6 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 58
TABLE 7 NORTH AMERICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 59
TABLE 8 NORTH AMERICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY 2019-2028 (USD MILLION) 60
TABLE 9 NORTH AMERICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY 2019-2028 (USD MILLION) 61
TABLE 10 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION) 66
TABLE 11 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 70
TABLE 12 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION) 78
TABLE 13 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION) 78
TABLE 14 NORTH AMERICA ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION) 78
TABLE 15 NORTH AMERICA ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION) 78
TABLE 16 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 79
TABLE 17 NORTH AMERICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 79
TABLE 18 NORTH AMERICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 79
TABLE 19 NORTH AMERICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 79
TABLE 20 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION) 80
TABLE 21 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 80
TABLE 22 U.S. CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION) 81
TABLE 23 U.S. ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION) 81
TABLE 24 U.S. ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION) 81
TABLE 25 U.S. CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 82
TABLE 26 U.S. CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 82
TABLE 27 U.S. MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 82
TABLE 28 U.S. HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 82
TABLE 29 U.S. CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION) 83
TABLE 30 U.S. CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 83
TABLE 31 CANADA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION) 84
TABLE 32 CANADA ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION) 84
TABLE 33 CANADA ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION) 84
TABLE 34 CANADA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 85
TABLE 35 CANADA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 85
TABLE 36 CANADA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 85
TABLE 37 CANADA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 85
TABLE 38 CANADA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION) 86
TABLE 39 CANADA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 86
TABLE 40 MEXICO CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION) 87
TABLE 41 MEXICO ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION) 87
TABLE 42 MEXICO ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION) 87
TABLE 43 MEXICO CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 88
TABLE 44 MEXICO CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 88
TABLE 45 MEXICO MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 88
TABLE 46 MEXICO HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION) 88
TABLE 47 MEXICO CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION) 89
TABLE 48 MEXICO CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 89

LIST OF FIGURES

FIGURE 1 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: SEGMENTATION 17
FIGURE 2 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: DATA TRIANGULATION 19
FIGURE 3 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: DROC ANALYSIS 20
FIGURE 4 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 21
FIGURE 5 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: COMPANY RESEARCH ANALYSIS 21
FIGURE 6 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: INTERVIEW DEMOGRAPHICS 23
FIGURE 7 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: DBMR MARKET POSITION GRID 24
FIGURE 8 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET APPLICATION COVERAGE GRID 26
FIGURE 9 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: VENDOR SHARE ANALYSIS 27
FIGURE 10 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: SEGMENTATION 31
FIGURE 11 RISING INFECTIOUS DISEASES WORLDWIDE AND RISING DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS ARE EXPECTED TO DRIVE THE NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028 32
FIGURE 12 ROUTINE TESTING SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET IN 2021 & 2028 32
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET 40
FIGURE 14 BELOW ARE BENEFITS THAT HAVE TO INCREASE THE ADOPTION OF DIGITAL PATHOLOGY PLATFORMS: 46
FIGURE 15 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2020 52
FIGURE 16 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, 2020 57
FIGURE 17 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, 2020 65
FIGURE 18 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2020 69
FIGURE 19 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: SNAPSHOT (2020) 75
FIGURE 20 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: BY COUNTRY (2020) 76
FIGURE 21 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: BY COUNTRY (2021 & 2028) 76
FIGURE 22 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: BY COUNTRY (2020 & 2028) 77
FIGURE 23 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE (2021 & 2028) 77
FIGURE 24 NORTH AMERICA CLINICAL LABORATORY SERVICES MARKET: COMPANY SHARE 2020 (%) 90